Human immunodeficiency virus type 1 infection and replication in normal human oral keratinocytes

Journal of Virology

Volumn 77, Issue 6, 2003, Pages 3470-3476

  Liu, Xuan ^a   Zha, Junli ^a   Chen, Hongying ^a   Nishitani, Junko ^a   Camargo, Paulo ^b   Cole, Steve W ^c   Zack, Jerome A ^c  

^a CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR5;

ARTICLE; COCULTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KERATINOCYTE; LYMPHOCYTE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROVIRUS; VIRION; VIRUS REPLICATION; VIRUS TRANSMISSION;

CELLS, CULTURED; DNA, VIRAL; HIV INFECTIONS; HIV-1; HUMANS; KERATINOCYTES; LEUKOCYTES, MONONUCLEAR; MOUTH MUCOSA; POLYMERASE CHAIN REACTION; PROVIRUSES; RECEPTORS, HIV; VIRUS REPLICATION;

EID: 0037334479     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.77.6.3470-3476.2003     Document Type: Article

References (50)

1. Adachi, A., H. E. Gendelman, S. Koenig, T. Folks, R. Willey, A. Rabson, and M. A. Martin. 1986. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59:284-291.
2. Alfsen, A., and M. Bomsel. 2002. HIV-1 gp41 envelope residues 650-685 exposed on native virus act as a lectin to bind epithelial cell galactosyl ceramide. J. Biol. Chem. 12:25649-25659.
3. Baba, T. W., A. M. Trichel, L. An, V. Liska, L. N. Martin, M. Murphey-Corb, and R. M. Ruprecht. 1996. Infection and AIDS in adult macaques after nontraumatic oral exposure to cell-free SIV. Science 272:1486-1489.
4. Baccetti, B., A. Benedetto, A. G. Burrini, G. Collodel, E. C. Ceccarini, N. Crisa, A. Di Caro, M. Estenoz, A. R. Garbuglia, A. Massacesi, et al. 1994. HIV-particles in spermatozoa of patients with AIDS and their transfer into the oocyte. J. Cell Biol. 127:903-914.
5. Bergey, E. J., M. I. Cho, B. M. Blumberg, M. L. Hammarskjold, D. Rekosh, L. G. Epstein, and M. J. Levine. 1994. Interaction of HIV-1 and human salivary mucins. J. Acquir. Immune Defic. Syndr. 7:995-1002.
6. Berson, J. F., D. Long, B. J. Doranz, J. Rucker, F. R. Jirik, and R. W. Doms. 1996. A seven-transmembrane domain receptor involved in fusion and entry of T-cell-tropic human immunodeficiency virus type 1 strains. J. Virol. 70:6288-6295.
7. Bhat, S., R. V. Mettus, E. P. Reddy, K. E. Ugen, V. Srikanthan, W. V. Williams, and D. B. Weiner. 1993. The galactosyl ceramide/sulfatide receptor binding region of HIV-1 gp120 maps to amino acids 206-275. AIDS Res. Hum. Retrovir. 9:175-181.
8. Bhat, S., S. L. Spitalnik, F. Gonzalez-Scarano, and D. H. Silberberg. 1991. Galactosyl ceramide or a derivative is an essential component of the neural receptor for human immunodeficiency virus type 1 envelope glycoprotein gp120. Proc. Natl. Acad. Sci. USA 88:7131-7134.
9. Bourinbaiar, A. S., and D. M. Phillips. 1991. Transmission of human immunodeficiency virus from monocytes to epithelia. J. Acquir. Immune Defic. Syndr. 4:56-63.
10. Chehimi, J., X. Ma, S. Chouaib, A. Zyad, T. Nagshunmugam, L. Wojcik, S. Chehimi, L. Nissim, and I. Frank. 1996. Differential production of interleukin 10 during human immunodeficiency virus infection. AIDS Res. Hum. Retrovir. 12:1141-1149.
11. Delezay, O., N. Koch, N. Yahi, D. Hammache, C. Tourres, C. Tamalet, and J. Fantini. 1997. Co-expression of CXCR4/fusin and galactosylceramide in the human intestinal epithelial cell line HT-29. AIDS 11:1311-1318.
12. Doranz, B. J., J. Rucker, Y. Yi, R. J. Smyth, M. Samson, S. C. Peiper, M. Parmentier, R. G. Collman, and R. W. Doms. 1996. A dualtropic primary HIV-1 isolate that uses fusion and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 85:1149-1158.
13. Endres, M. J., P. R. Clapham, M. Marsh, M. Ahuja, J. D. Turner, A. McKnight, J. F. Thomas, B. Stoebenau-Haggarty, S. Choe, P. J. Vance, T. N. Wells, C. A. Power, S. S. Sutterwala, R. W. Doms, N. R. Landau, and J. A. Hoxie. 1996. CD4-independent infection by HIV-2 is mediated by fusin/CXCR4. Cell 87:745-756.
14. + dendritic cells in human blood transmits HIV-1 to T lymphocytes. Blood 1:1780-1786.
15. Fantini, J., D. G. Cook, N. Nathanson, S. L. Spitalnik, and F. Gonzalez-Scarano. 1993. Infection of colonic epithelial cell lines by type 1 human immunodeficiency virus is associated with cell surface expression of galactosylceramide, a potential alternative gp120 receptor. Proc. Natl. Acad. Sci. USA 90:2700-2704.
16. Fantini, J., D. Hammache, O. Delezay, N. Yahi, C. Andre-Barres, I. Rico-Lattes, and A. Lattes. 1997. Synthetic soluble analogs of galactosylceramide (GalCer) bind to the V3 domain of HIV-1 gp120 and inhibit HIV-1-induced fusion and entry. J. Biol. Chem. 14:7245-7252.
17. Faruque, S., B. R. Edlin, C. B. McCoy, C. O. Word, S. A. Larsen, D. S. Schmid, J. C. Von Bargen, and Y. Serrano. 1996. Crack cocaine smoking and oral sores in three inner-city neighborhoods. J. Acquir. Immune Defic. Syndr. 13:87-92.
18. Fultz, P. 1986. Components of saliva inactivate human immunodeficiency virus. Lancet ii:1215.
19. Furuta, Y., K. Eriksson, B. Svennerholm, P. Fredman, P. Horal, S. Jeansson, A. Vahlne, J. Holmgren, and C. Czerkinsky. 1994. Infection of vaginal and colonic epithelial cells by the human immunodeficiency virus type I is neutralized by antibodies raised against conserved epitopes in the envelope glycoprotein gp120. Proc. Natl. Acad. Sci. USA 91:12559-12563.
20. Gartner, S., P. Markovits, D. M. Markovitz, R. F. Betts, and M. Popovic. 1986. Virus isolation from and identification of HTLV-III/LAV-producing cells in brain tissue from a patient with AIDS. JAMA 256:2365-2371.
21. Gendelman, H. E., J. M. Orenstein, L. M. Baca, B. Weiser, H. Burger, D. C. Kalter, and M. S. Meltzer. 1989. The macrophage in the persistence and pathogenesis of HIV infection. AIDS 3:475-495.
22. Harouse, J. M., S. Bhat, S. L. Spitalnik, M. Laughlin, K. Stefano, D. H. Silberberg, and F. Gonzalez-Scarano. 1991. Inhibition of entry of HIV-1 in neural cell lines by antibodies against galactosyl ceramide. Science 253:320-323.
23. Janoff, E. N., R. W. Scamurra, T. C. Sanneman, K. Eidman, and J. R. Thurn. 1999. Human immunodeficiency virus type 1 and mucosal humoral defense. J. Infect. Dis. 179:S475-S479.
24. Koyanagi, Y., S. Miles, R. T. Mitsuyasu, J. E. Merrill, H. V. Vinters, and I. S. Chen. 1987. Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms. Science 236:819-822.
25. Lafferty, W. E., J. P. Hughes, and H. H. Handsfield. 1997. Sexually transmitted diseases in men who have sex with men: acquisition of gonorrhea and nongonococcal urethritis by fellatio and implications for STD/HIV prevention. Sex. Transm. Dis. 24:272-278.
26. Lapham, C. K., J. Ouyang, B. Chandrasekhar, N. Y. Nguyen, D. S. Dimitrov, and H. Golding. 1996. Evidence for cell-surface association between fusin and the CD4-gp120 complex in human cell lines. Science 274:602-605.
27. Lifson, A. R., P. M. O'Malley, N. A. Hessol, S. P. Buchbinder, L. Cannon, and G. W. Rutherford. 1990. HIV seroconversion in two homosexual men after receptive oral intercourse with ejaculation: implications for counseling concerning safe sexual practices. Am. J. Public Health 80:1509-1511.
28. Liuzzi, G., A. Chirianni, M. Clementi, P. Bagnarelli, A. Valenza, P. T. Cataldo, and M. Piazza. 1996. Analysis of HIV-1 load in blood, semen and saliva: evidence for different viral compartments in a cross-sectional and longitudinal study. AIDS 10:F51-F56.
29. Maddon, P. J., A. G. Dalgleish, J. S. McDougal, P. R. Clapham, R. A. Weiss, and R. Axel. 1986. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell 47:333-348.
30. Park, N.-H., B. M. Min, S. L. Li, M. Z. Huang, H. M. Cherick, and J. Doniger. 1991. Immortalization of normal human oral keratinocytes with type 16 human papillomavirus. Carcinogenesis 12:1627-1631.
31. Phillips, D. M., and A. S. Bourinbaiar. 1992. Mechanism of HIV spread from lymphocytes to epithelia. Virology 186:261-273.
32. Qureshi, M. N., C. E. Barr, I. Hewlitt, R. Boorstein, F. Kong, O. Bagasra, L. E. Bobroski, and B. Joshi. 1997. Detection of HIV in oral mucosal cells. Oral Dis. 3:S73-S78.
33. Qureshi, M. N., C. E. Barr, T. Seshamma, J. Reidy, R. J. Pomerantz, and O. Bagasra. 1995. Infection of oral mucosal cells by human immunodeficiency virus type 1 in seropositive persons. J. Infect. Dis. 171:190-193.
34. Rizzuto, C. D., R. Wyatt, N. Hernandez-Ramos, Y. Sun, P. D. Kwong, W. A. Hendrickson, and J. Sodroski. 1998. A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding. Science 280:1949-1953.
35. Robinovitch, M. R., J. M. Iversen, and L. Resnick. 1993. Anti-infectivity activity of human salivary secretions toward human immunodeficiency virus. Crit. Rev. Oral Biol. Med. 4:455-459.
36. Rothenberg, R. B., M. Scarlett, C. del Rio, D. Reznik, and C. O'Daniels. 1998. Oral transmission of HIV. AIDS 12:2095-2105.
37. Samuel, M. C., N. Hessol, S. Shiboski, R. R. Engel, T. P. Speed, and W. Winkelstein, Jr. 1993. Factors associated with human immunodeficiency virus seroconversions in homosexual men in three San Francisco cohort studies. J. Acquir. Immune Defic. Syndr. 6:303-312.
38. Schwarcz, S. K., T. A. Kellogg, R. P. Kohn, M. H. Katz, G. F. Lemp, and G. A. Bolan. 1995. Temporal trends in human immunodeficiency virus seroprevalence and sexual behavior at the San Francisco municipal sexually transmitted disease clinic, 1989-1992. Am. J. Epidemiol. 142:314-322.
39. Shine, N., K. Konopka, and N. Duzgunes. 1997. The anti-HIV-1 activity associated with saliva. J. Dent. Res. 76:634-640.
40. Shugars, D. C., and S. M. Wahl. 1998. The role of the oral environment in HIV-1 transmission. J. Am. Dent. Assoc. 129:851-858.
41. Spencer, J. D., N. Latt, P. J. Beeby, E. Collins, J. B. Saunders, G. W. McCaughan, and Y. E. Cossart. 1997. Transmission of hepatitis C virus to infants of human immunodeficiency virus-negative intravenous drug-using mothers: rate of infection and assessment of risk factors for transmission. J. Viral Hepatitis 4:395-409.
42. Stahl-Hennig, C., R. M. Steinman, K. Tenner-Racz, M. Pope, N. Stolte, K. Matz-Rensing, G. Grobschupff, B. Raschdorff, G. Hunsmann, and P. Racz. 1999. Rapid infection of oral mucosal-associated lymphoid tissue with simian immunodeficiency virus. Science 285:1261-1265.
43. Tan, X., R. Pearce-Pratt, and D. M. Phillips. 1993. Productive infection of a cervical epithelial cell line with human immunodeficiency virus: implications for sexual transmission. J. Virol. 67:6447-6452.
44. Tateno, M., F. Gonzalez-Scarano, F., and J. A. Levy. 1989. Human immunodeficiency virus can infect CD4-negative human fibroblastoid cells. Proc. Natl. Acad. Sci. USA 86:4287-4290.
45. Weber, K. T., D. Hammache, J. Fantini, and B. Ganem. 2000. Synthesis of glycolipid analogues that disrupt binding of HIV-1 gp120 to galactosylceramide. Bioorg. Med. Chem. Lett. 15:1011-1014.
46. Yahi, N., S. Baghdiguian, H. Moreau, and J. Fantini. 1992. Galactosyl ceramide (or a closely related molecule) is the receptor for human immunodeficiency virus type 1 on human colon epithelial HT29 cells. J. Virol. 66:4848-4854.
47. Yahi, N., J. M. Sabatier, S. Baghdiguian., F. Gonzalez-Scarano, and J. Fantini. 1995. Synthetic multimeric peptides derived from the principal neutralization domain (V3 loop) of human immunodeficiency virus type 1 (HIV-1) gp120 bind to galactosylceramide and block HIV-1 infection in a human CD4-negative mucosal epithelial cell line. J. Virol. 69:320-325.
48. Yahi, N., S. L. Spitalnik, K. A. Stefano, P. De Micco, F. Gonzalez-Scarano, and J. Fantini. 1994. Interferon-gamma decreases cell surface expression of galactosyl ceramide, the receptor for HIV-1 GP120 on colonic epithelial cells. Virology 204:550-557.
49. Zack, J. A., S. J. Arrigo, S. R. Weitsman, A. S. Go, A. Haislip, and I. S. Chen. 1990. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 61:213-222.
50. Zhang, L., T. He, Y. Huang, Z. Chen, Y. Guo, S. Wu, K. J. Kunstman, R. C. Brown, J. P. Phair, A. U. Neumann, D. D. Ho., and S. M. Wolinsky. 1998. Chemokine coreceptor usage by diverse primary isolates of human immunodeficiency virus type 1. J. Virol. 72:9307-9312.